SEC Form 4 · accession 0001556064-26-000002
Black Diamond Therapeutics, Inc. · BDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garry E Menzel
Director
Period of report
Jun 26, 2026
Accepted (ET)
Jun 29, 2026 · 4:37 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001701541
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.71 | Jun 26, 2026 | A | 40,000 | A | — | Jun 25, 2036 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 26, 2027 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.